InfuSystem Schedules 2012 Annual Meeting of Stockholders

MADISON HEIGHTS, Mich., Feb. 21, 2012 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE Amex:INFU) ("Company"), the leading national provider of infusion pumps and related services, today announced that the Company's Annual Meeting of Stockholders (the "Annual Meeting") has been scheduled for Monday, May 7, 2012 at 10:00 a.m. ET. InfuSystem stockholders of record at the close of business on March 20, 2012 will be entitled to receive notice and to vote at this year's Annual Meeting. 

The meeting will be held at the Company's offices located at 31700 Research Park Drive, Madison Heights, Michigan 48071. Further details regarding the meeting will be included in the Company's definitive proxy statement, which InfuSystem will mail to stockholders of record in advance of the Annual Meeting.

About InfuSystem Holdings, Inc.

InfuSystem Holdings, Inc. is the leading provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers.  Headquartered in Madison Heights, Michigan, the company delivers local, field-based customer support, and also operates Centers of Excellence in Michigan, Kansas, California, and Ontario, Canada. The Company's stock is traded on the NYSE Amex under the symbol INFU.

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those predicted by such forward-looking statements. These risks and uncertainties include general economic conditions, as well as other risks, detailed from time to time in the company's publicly filed documents.

Additional Information and Where to Find It

In connection with the solicitation of agent designation revocations, InfuSystem Holdings, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (the "SEC"). STOCKHOLDERS ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT AND OTHER RELEVANT MATERIALS WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN IMPORTANT INFORMATION. InfuSystem and its directors and executive officers may be deemed to be participants in the solicitation of agent designation revocations. Stockholders may obtain additional information regarding such participants and their interests from the definitive proxy statement and from InfuSystem's periodic reports filed with the SEC. The periodic reports and definitive proxy statement are available, and other relevant documents will be available, at no charge at the web site of the SEC, at www.sec.gov.

CONTACT: INVESTOR CONTACT:
         Pat LaVecchia
         Vice Chairman
         Info@InfuSystem.com
         Tel: (800) 962-9656

         MEDIA CONTACT:
         David Haar
         Info@InfuSystem.com
         Tel: (800) 962-9656

Released February 21, 2012